Literature DB >> 25822421

[Ventricular long-term support with implantable continuous flow pumps: on the way to a gold standard in the therapy of terminal heart failure].

T Krabatsch1, E Potapov, S Soltani, M Dandel, V Falk, C Knosalla.   

Abstract

Mechanical circulatory support nowadays represents an important option in the treatment of patients with advanced heart insufficiency. Once developed as a bridging to heart transplantation, it is now a valuable option for permanent support in patients for whom a heart transplantation is not possible due to contraindications or a lack of available organs. Furthermore, it can be used as a bridging to myocardial recovery and explantation. The number of implantations of left ventricular assist devices (LVAD) has clearly increased in recent years and approximately one half of these implantations is already carried out in centers not specialized in transplantations. This development necessitates that every practicing physician is aware of the basic principles of mechanical circulatory support and with the possible complications. This article gives a summary of the current state of the technology and treatment of patients with long-term VADs.

Entities:  

Mesh:

Year:  2015        PMID: 25822421     DOI: 10.1007/s00059-015-4209-3

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  36 in total

1.  Third INTERMACS Annual Report: the evolution of destination therapy in the United States.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2011-02       Impact factor: 10.247

2.  Load dependency of right ventricular performance is a major factor to be considered in decision making before ventricular assist device implantation.

Authors:  Michael Dandel; Evgenij Potapov; Thomas Krabatsch; Alexander Stepanenko; Alexandra Löw; Juliane Vierecke; Christoph Knosalla; Roland Hetzer
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

3.  Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.

Authors:  Mark S Slaughter; Michael A Sobieski; Joel D Graham; Patroklos S Pappas; Antone J Tatooles; Steven C Koenig
Journal:  Int J Artif Organs       Date:  2011-06       Impact factor: 1.595

4.  Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices.

Authors:  Michael Dandel; Yuguo Weng; Henryk Siniawski; Evgenij Potapov; Thomas Krabatsch; Hans B Lehmkuhl; Thorsten Drews; Christoph Knosalla; Roland Hetzer
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

5.  Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.

Authors:  Jennifer A Cowger; Matthew A Romano; Palak Shah; Neha Shah; Vivek Mehta; Jonathan W Haft; Keith D Aaronson; Francis D Pagani
Journal:  J Heart Lung Transplant       Date:  2013-11-28       Impact factor: 10.247

6.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.

Authors:  Sang-Woo Pak; Nir Uriel; Hiroo Takayama; Sarah Cappleman; Robert Song; Paolo C Colombo; Sandy Charles; Donna Mancini; Linda Gillam; Yoshifumi Naka; Ulrich P Jorde
Journal:  J Heart Lung Transplant       Date:  2010-07-08       Impact factor: 10.247

7.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Authors:  Randall C Starling; Yoshifumi Naka; Andrew J Boyle; Gonzalo Gonzalez-Stawinski; Ranjit John; Ulrich Jorde; Stuart D Russell; John V Conte; Keith D Aaronson; Edwin C McGee; William G Cotts; David DeNofrio; Duc Thinh Pham; David J Farrar; Francis D Pagani
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

8.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

9.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

10.  Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique.

Authors:  Evgenij V Potapov; Alexander Stepanenko; Friedrich Kaufmann; Ewald Henning; Juliana Vierecke; Elke Lehmkuhl; Roland Hetzer; Thomas Krabatsch
Journal:  ASAIO J       Date:  2013 Jan-Feb       Impact factor: 2.872

View more
  1 in total

Review 1.  [Hemodynamics and physical capacity in patients with left ventricular assist devices : An overview].

Authors:  N Reiss; M Altesellmeier; S Mommertz; T Schmidt; S Schulte-Eistrup; D Willemsen
Journal:  Herz       Date:  2016-02-11       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.